Symetis TF ACURATEneo™ Valve-in-Valve: A New Indication for Another Self-Expanding TAVI Prosthesis?
|
Elton Pllaha1,2, Paolo Pagnotta1, Marco Rossi1, Bernhard Reimers1 1Istituto Clinico Humanitas, Department of Cardiology, Haemodynamic Unit, Milan, Italy2Electronic correspondence: epllaha@yahoo.com |
|
|
During the past decade there has been a major shift in the use of surgical bioprostheses. Consequently, due to the increasing age of the population there will be a major increase in the incidence of failure of these prostheses. While mortality associated with the re-replacement of surgical valve failures remains high, advances in transcatheter interventions have permitted the use of transcatheter valves in degenerative surgical bioprostheses. |
Herein is described the first use of the Symetis transfemoral ACURATEneo™ valve-in-valve procedure, together with details of the associated technical challenges. Video 1: Positioning of the TAVI prosthesis. Video 2: Valve deployment.The Journal of Heart Valve Disease 2017;26:32-36 |
| Symetis TF ACURATEneo™ Valve-in-Valve: A New Indication for Another Self-Expanding TAVI Prosthesis? | |
Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.
Purchase this Article
Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.
Website by CHP Design, London